Traws Pharma, Inc. Quarterly Other Assets, Current in USD from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Traws Pharma, Inc. quarterly Other Assets, Current history and growth rate from Q4 2012 to Q2 2024.
  • Traws Pharma, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $583K, a 121% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $583K +$319K +121% Jun 30, 2024 10-Q 2024-08-15
Q1 2024 $263K +$195K +287% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $401K +$361K +903% Dec 31, 2023 10-Q 2024-08-15
Q3 2023 $303K $0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $264K -$42K -13.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $68K -$238K -77.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $40K +$5K +14.3% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $303K +$206K +212% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $306K +$115K +60.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $306K +$93K +43.7% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $35K -$145K -80.6% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $97K -$100K -50.8% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $191K -$121K -38.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $213K -$9K -4.05% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $180K +$40K +28.6% Dec 31, 2020 10-K 2022-03-21
Q3 2020 $197K +$108K +121% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $312K +$221K +243% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $222K +$120K +118% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 $140K +$72K +106% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $89K -$14K -13.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $91K +$8K +9.64% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $102K -$123K -54.7% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $68K -$9K -11.7% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $103K -$18K -14.9% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $83K -$1K -1.19% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $225K +$121K +116% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $77K +$4K +5.48% Dec 31, 2017 10-K 2019-04-01
Q3 2017 $121K +$24K +24.7% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $84K -$185K -68.8% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $104K -$102K -49.5% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $73K -$122K -62.6% Dec 31, 2016 10-K 2018-03-16
Q3 2016 $97K -$17K -14.9% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $269K -$9K -3.24% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $206K -$81K -28.2% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $195K -$60K -23.5% Dec 31, 2015 10-K 2017-03-29
Q3 2015 $114K -$298K -72.3% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $278K -$59K -17.5% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $287K -$233K -44.8% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $255K -$194K -43.2% Dec 31, 2014 10-K 2016-03-28
Q3 2014 $412K +$17K +4.3% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $337K -$846K -71.5% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 $520K Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $449K +$254K +130% Dec 31, 2013 10-K 2015-03-30
Q3 2013 $395K Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $1.18M Jun 30, 2013 10-Q 2013-09-06
Q4 2012 $195K Dec 31, 2012 10-K 2014-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.